<ul>
	<li>Serious Infections: Avoid use of Tofacitinib during an active serious infection, including localized infections.&nbsp;</li>
	<li>Gastrointestinal Perforations: Use with caution in patients that may be at increased risk.</li>
	<li>Laboratory Monitoring: Recommended due to potential changes in lymphocytes, neutrophils, hemoglobin, liver enzymes and lipids.</li>
	<li>Immunizations: Live vaccines: Avoid use with Tofacitinib.</li>
	<li>Do not initiate Tofacitinib&nbsp;if absolute lymphocyte count &lt;500 cells/mm3, an absolute neutrophil count (ANC) &lt;1000 cells/mm3 or hemoglobin &lt;9 gm/dL.</li>
</ul>